Evercore ISI Group Reiterates Outperform Rating on Edwards Lifesciences Corporation (EW)

Market Context

Edwards Lifesciences Corporation operates in the Healthcare sector. The stock currently trades at $99.64 with a market capitalization of $49.5B. The stock has gained 17.5% over the past 52 weeks.

Analyst coverage from Evercore ISI Group provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Edwards Lifesciences Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Edwards Lifesciences Corporation

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Nov 05, 2026	Evercore ISI Group	Outperform	N/A
Nov 05, 2026	BTIG	Buy	N/A
Nov 04, 2026	Truist Securities	Buy	N/A
Oct 07, 2026	Barclays	Overweight	N/A
Sep 11, 2026	BTIG	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View EW Stock Page